Sort   by:  
 Page size 
UnknownCase Report: FGFR2 inhibitor resistance via <i>PIK3CA</i> and <i>CDKN2A/B</i> in an intrahepatic cholangiocarcinoma patient with <i>FGFR2-SH3GLB1</i> fusion.
Not available
S-EPMC12009697 | biostudies-literature
UnknownHLA class I-restricted MYD88 L265P-derived peptides as specific targets for lymphoma immunotherapy.
Not available
S-EPMC5384368 | biostudies-literature
UnknownCREBBP gene mutations are frequently detected in in situ follicular neoplasia.
Not available
S-EPMC6302496 | biostudies-literature
UnknownDasatinib overrides the differentiation blockage in a patient with mutant-KIT D816V positive CBFβ-MYH11 leukemia.
Not available
S-EPMC5837740 | biostudies-literature
ProteomicsThe oncogenic fusion protein DNAJB1-PRKACA can be specifically targeted by peptide-based immunotherapy in fibrolamellar hepatocellular carcinoma
The DNAJB1-PRKACA fusion transcript is the oncogenic driver in fibrolamellar hepatocellular carcinoma, a lethal disease lacking specific therapies. This study reports on the identification, characterization, and immunotherapeutic application of HLA-presented neoantigens specific for the DNAJB1-PRKAC...
ORGANISM(S): Homo sapiens (Human) 
2022-10-13 | PXD029882 | Pride
Cancer Hla ligands Mass spectrometry Fibrolamellar hepatocellular carcinoma Immunopeptidomics Fl-hcc 
UnknownDiffuse large B-cell lymphomas in adults with aberrant coexpression of CD10, BCL6, and MUM1 are enriched in IRF4 rearrangements.
Not available
S-EPMC9006278 | biostudies-literature
UnknownA unifying hypothesis for PNMZL and PTFL: morphological variants with a common molecular profile.
Not available
S-EPMC9631662 | biostudies-literature
UnknownThe oncogenic fusion protein DNAJB1-PRKACA can be specifically targeted by peptide-based immunotherapy in fibrolamellar hepatocellular carcinoma.
Not available
S-EPMC9613889 | biostudies-literature
TranscriptomicsFollicular lymphoma in situ and partial involvement by follicular lymphoma are clona lesions that carry the t(14;18) and lack genetic secondary alterations
Follicular lymphoma (FL) is characterized by the t(14;18)(q32;q21), frequent numerical chromosomal alterations, and recurrent somatic mutations. However, no genetic studies are available for FL in situ (FLIS), a putative precursor lesion of FL. In this study, we analyzed cases of FLIS without manife...
ORGANISM(S): Homo sapiens 
2013-11-12 | E-GEOD-48548 | biostudies-arrayexpress
UnknownThe molecular hallmarks of primary and secondary vitreoretinal lymphoma.
Not available
S-EPMC8905692 | biostudies-literature
Sort   by:  
 Page size